Search Results - "Bode‐Böger, Stefanie M."

Refine Results
  1. 1
  2. 2

    Dimethylarginines ADMA and SDMA: The Real Water-Soluble Small Toxins? by Schepers, Eva, MBScE, PhD, Speer, Timo, MD, PhD, Bode-Böger, Stefanie M., MD, MPH, Fliser, Danilo, MD, Kielstein, Jan T., MD

    Published in Seminars in nephrology (01-03-2014)
    “…Summary Uremia occurs if the kidney loses the ability to eliminate toxic compounds at a sufficient rate into the urine. In 1970, N-N, N-G- and…”
    Get full text
    Journal Article
  3. 3

    Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension by Kielstein, Jan T, Bode-Böger, Stefanie M, Hesse, Gerrit, Martens-Lobenhoffer, Jens, Takacs, Attila, Fliser, Danilo, Hoeper, Marius M

    “…OBJECTIVE—We explored the potential role of the endogenous NO synthase inhibitor asymmetrical dimethylarginine (ADMA) in patients with idiopathic pulmonary…”
    Get full text
    Journal Article
  4. 4

    Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans by KIELSTEIN, Jan T, IMPRAIM, Burcu, SIMMEL, Solveig, BODE-BÖGER, Stefanie M, TSIKAS, Dimitrios, FROLICH, Jürgen C, HOEPER, Marius M, HALLER, Hermann, FLISER, Danilo

    Published in Circulation (New York, N.Y.) (20-01-2004)
    “…Increased blood concentrations of the endogenous nitric oxide synthase (NOS) inhibitor asymmetrical dimethylarginine (ADMA) have been linked to excess…”
    Get full text
    Journal Article
  5. 5

    LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells: Involvement of S-Adenosylmethionine–Dependent Methyltransferases by Böger, Rainer H, Sydow, Karsten, Borlak, Jürgen, Thum, Thomas, Lenzen, Henrike, Schubert, Bibiana, Tsikas, Dimitrios, Bode-Böger, Stefanie M

    Published in Circulation research (21-07-2000)
    “…Asymmetrical dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor. It is formed by protein arginine N-methyltransferases (PRMTs), which…”
    Get full text
    Journal Article
  6. 6

    Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects by KIELSTEIN, Jan T, BODE-BÖGER, Stefanie M, FRÖLICH, Jürgen C, RITZ, Eberhard, HALLER, Hermann, FLISER, Danilo

    Published in Circulation (New York, N.Y.) (15-04-2003)
    “…Reduced availability of nitric oxide (NO) is thought to contribute to the age-associated increase of renovascular tone and blood pressure. We assessed blood…”
    Get full text
    Journal Article
  7. 7

    Determination of micafungin and anidulafungin in human plasma: UV- or mass spectrometric quantification? by Martens-Lobenhoffer, Jens, Rupprecht, Victoria, Bode-Böger, Stefanie M.

    “…Micafungin and anidulafungin are two newer antifungal drugs from the echinocandine class. They are used as monotherapy or in combination with azole-antifungal…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Association of dimethylarginines and mediators of inflammation after acute ischemic stroke by Chen, Shufen, Martens-Lobenhoffer, Jens, Weissenborn, Karin, Kielstein, Jan T, Lichtinghagen, Ralf, Deb-Chatterji, Milani, Li, Na, Tryc, Anita B, Goldbecker, Annemarie, Dong, Qiang, Bode-Böger, Stefanie M, Worthmann, Hans

    Published in Journal of neuroinflammation (17-11-2012)
    “…Elevated levels of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are accompanied by endothelial dysfunction and predict adverse…”
    Get full text
    Journal Article
  10. 10

    The Second Life of Methylarginines as Cardiovascular Targets by Jarzebska, Natalia, Mangoni, Arduino A, Martens-Lobenhoffer, Jens, Bode-Böger, Stefanie M, Rodionov, Roman N

    “…Endogenous methylarginines were proposed as cardiovascular risk factors more than two decades ago, however, so far, this knowledge has not led to the…”
    Get full text
    Journal Article
  11. 11

    An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes by Böger, Rainer H, Bode-Böger, Stefanie M, Tsao, Philip S, Lin, Patrick S, Chan, Jason R, Cooke, John P

    “…OBJECTIVES We sought to determine whether asymmetric dimethylarginine (ADMA) inhibits nitric oxide (NO) elaboration in cultured human endothelial cells and…”
    Get full text
    Journal Article
  12. 12

    Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism by Rodionov, Roman N., Beyer-Westendorf, Jan, Bode-Böger, Stefanie M., Eggebrecht, Lisa, Konstantinides, Stavros, Martens-Lobenhoffer, Jens, Nagler, Markus, Prochaska, Jürgen, Wild, Philipp

    Published in Scientific reports (05-05-2021)
    “…Endogenous arginine derivatives homoarginine, asymmetric dimethylarginine (ADMA) and symmetric dimethyarginine (SDMA) are independent mortality predictors in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study by König, Christina, Martens-Lobenhoffer, Jens, Czorlich, Patrick, Westphal, Manfred, Bode-Böger, Stefanie M, Kluge, Stefan, Grensemann, Jörn

    “…For treatment of ventriculitis, vancomycin and meropenem are frequently used as empiric treatment but cerebrospinal fluid (CSF) penetration is highly variable…”
    Get full text
    Journal Article
  16. 16

    L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship by BodeBöger, Stefanie M., Böger, Rainer H., Galland, Andrea, Tsikas, Dimitrios, Frölich, Jürgen C.

    Published in British journal of clinical pharmacology (01-11-1998)
    “…Aims Administration of l‐arginine by intravenous infusion or via oral absorption has been shown to induce peripheral vasodilation in humans, and to improve…”
    Get full text
    Journal Article
  17. 17

    Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans by Chan, Jason R, Böger, Rainer H, Bode-Böger, Stefanie M, Tangphao, Oranee, Tsao, Philip S, Blaschke, Terrence F, Cooke, John P

    “…ABSTRACTAsymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is elevated in hypercholesterolemia. This study was designed to…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    The impact of rapid atrial pacing on ADMA and endothelial NOS by Goette, Andreas, Hammwöhner, Matthias, Bukowska, Alicja, Scalera, Fortunato, Martens-Lobenhoffer, Jens, Dobrev, Dobromir, Ravens, Ursula, Weinert, Soenke, Medunjanin, Senad, Lendeckel, Uwe, Bode-Böger, Stefanie M

    Published in International journal of cardiology (26-01-2012)
    “…Abstract Background The endothelial nitric oxide synthase (eNOS) inhibitor asymmetric dimethylarginine (ADMA) is a well-established risk factor for oxidative…”
    Get full text
    Journal Article